Abstract
The current monkeypox outbreak as a global health emergency now spreads into more than 90 counties. Rapid and accurate diagnosis of the infections is fundamental for the viral disease containment. Here, we analyzed the primer and probe sequences in the CDC recommended monkeypox virus (MPV) generic real-time PCR assay by aligning against 683 reported MPV genomes worldwide. Sequence mismatches were found in more than 92% of genomes for the MPV generic forward and reverse primers. We also evaluated the specificity of seven other real-time PCR assays for MPV and orthopoxvirus (OPV) detection, and identified two assays (MPV_F3L and OPV_F8L) with the highest matching score (>99.4%) to the global MPV genome database. Genetic variations on the MPV genomes corresponding with the real-time PCR primer and probe regions were further specified and used to indicate the temporal and spatial emergence pattern of monkeypox disease. Our results show that the current MPV real-time generic assay may be unsuitable to accurately detect MPV, highlighting the need to develop new detection assays.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work is supported by Faculty Startup funding from the Center of Infectious Diseases at UTHealth, the UT system Rising STARs award, and the Texas Epidemic Public Health Institute (TEPHI) to F.W.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
1
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
3
Blogs/Media
Author Videos